Can a D-dimer (D-dimer test) be elevated with infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can D-dimer Be Elevated with Infection?

Yes, D-dimer is frequently elevated in infections including sepsis, pneumonia, and other infectious states, and this elevation is clinically significant for risk stratification and prognosis. 1

Infection as a Cause of D-dimer Elevation

D-dimer elevates in infection through multiple mechanisms related to the inflammatory and coagulation cascade activation that occurs during severe infectious processes:

  • Sepsis is one of the most common causes of markedly elevated D-dimer levels, with the International Society on Thrombosis and Haemostasis recognizing that coagulopathy development in sepsis from various infectious agents is a key feature associated with poor outcomes 1

  • Pneumonia specifically causes D-dimer elevation, with research demonstrating that elevated plasma D-dimer in adult community-acquired pneumonia patients correlates with increased inflammatory markers (WBC, hs-CRP, PCT) and predicts ICU admission and 30-day mortality 2

  • The American College of Cardiology explicitly states that treatment of bacterial superinfections is important when managing elevated D-dimer and coagulopathy, acknowledging infection as a direct cause 1

Clinical Significance in COVID-19 Infection

The COVID-19 pandemic provided extensive evidence of infection-related D-dimer elevation:

  • D-dimer ≥0.5 mg/L was noted in 46.4% of COVID-19 patients tested, with 60% of patients with severe illness demonstrating this elevation 1

  • Markedly elevated D-dimer (three- to fourfold increase) in COVID-19 patients warrants hospital admission even without other severe symptoms, as this signifies increased thrombin generation 1

  • D-dimer >2.12 μg/mL in COVID-19 patients was associated with mortality, compared to 0.61 μg/mL in survivors 1

Magnitude of Elevation Matters

The degree of D-dimer elevation in infection has prognostic implications:

  • Ultra-high D-dimer levels (>5000 ng/mL) occur in multiple conditions including sepsis, pneumonia, and other infections, with one study showing sepsis in 24% and pneumonia in a significant proportion of patients with these extreme elevations 3, 4

  • D-dimer >6 times the upper limit of normal is a consistent predictor of thrombotic events and poor overall prognosis in infected patients 1

  • When D-dimer levels are >15,000 ng/mL without a clear diagnosis, mortality reaches 75%, indicating severe underlying disease often including infection 3

Critical Clinical Pitfall

The major pitfall is assuming elevated D-dimer always indicates thromboembolism and missing the underlying infection:

  • D-dimer can be elevated in infection, cancer, recent surgery/trauma, pregnancy, advanced age, liver disease, and inflammatory states 5

  • Even very high D-dimer levels (>5000 ng/mL) in symptomatic patients may not indicate pulmonary embolism, as demonstrated in a case of COPD exacerbation with D-dimer of 5.58 μg/mL where CT angiography ruled out PE 6

  • 89% of patients with extremely elevated D-dimer (>5000 μg/L) had VTE, sepsis, and/or cancer, meaning infection accounts for a substantial proportion alongside thrombosis 4

Practical Management Algorithm

When encountering elevated D-dimer in a patient with suspected or confirmed infection:

  1. Risk stratify based on magnitude: D-dimer 3-4 times normal warrants admission; >6 times normal predicts poor prognosis 1

  2. Monitor coagulation parameters: Check PT, platelet count, and fibrinogen to identify evolving coagulopathy or DIC 1

  3. Don't rule out thrombosis solely based on infection presence: The International Society on Thrombosis and Haemostasis recommends obtaining D-dimer, PTT, platelet count, and fibrinogen for risk stratification in infected patients, as both infection and thrombosis may coexist 1

  4. Initiate prophylactic anticoagulation in hospitalized patients with markedly elevated D-dimer unless contraindicated (active bleeding or platelets <25 × 10⁹/L) 7

  5. Treat the underlying infection aggressively, as the American College of Cardiology emphasizes that treatment of bacterial superinfections is important when managing coagulopathy 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The clinical significance of ultra-high D-dimer levels.

Journal of vascular surgery. Venous and lymphatic disorders, 2022

Guideline

Elevated D-dimer Levels and Clinical Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Significantly Elevated D-Dimer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.